Parapsoriasishttps://en.wikipedia.org/wiki/Parapsoriasis
Parapsoriasis amatanthauza gulu limodzi la matenda a khungu omwe amadziwika makamaka ndi kufanana kwawo ndi psoriasis (zotupa zofiira, zotupa). Parapsoriasis ndi matenda osowa amtundu wa lymphoproliferative omwe amapezeka makamaka mwa akulu azaka zapakati, 2/3 mwa iwo ndi amuna.

Khansara yapakhungu ikhoza kupangidwa kuchokera ku parapsoriasis. Mwachitsanzo, imatha kukhala yamtundu wa T-cell lymphoma.

○ Kuzindikira ndi Chithandizo
Kuyeza magazi kuti athetse chindoko
Biopsy kuti athetse ma lymphoma a cutaneous

☆ Muzotsatira za 2022 Stiftung Warentest zochokera ku Germany, kukhutitsidwa kwa ogula ndi ModelDerm kunali kotsika pang'ono kusiyana ndi kuyankhulana kwa telemedicine komwe kulipiridwa.
      References Parapsoriasis-A Diagnosis with an Identity Crisis: A Narrative Review 35426607 
      NIH
      Parapsoriasis is an uncommon inflammatory skin disease characterized by chronic patches that may be resistant to therapy. It was primarily introduced and classified 120 years ago, and the original classification incorporated parapsoriasis and pityriasis lichenoides under the umbrella term parapsoriasis. After a major change in classification, parapsoriasis now exclusively refers to small plaque parapsoriasis (SPP) and large plaque parapsoriasis (LPP). However, debates still frequently occur regarding various nomenclatures and classifications used by different authors. Moreover, parapsoriasis may progress to overt cutaneous lymphoma, most commonly mycosis fungoides (MF), and it is very difficult to distinguish these two conditions despite modern histologic and molecular testing techniques.
       Histopathologic Evaluation of Parapsoriasis from the Perspective of NB-UVB/PUVA Therapy on the Outcome and Recurrence of the Disease 33911303 
      NIH
      Parapsoriasis, presented as an early stage of cutaneous T-cell lymphoma, is mostly treated with psoralen and ultraviolet A (PUVA) therapy and narrowband ultraviolet B (NB-UVB) phototherapy.